-
Senate Confirms Gail Slater as Justice Dept.’s Antitrust Lead
Slater, a longtime Washington lawyer, has been particularly critical of power in the tech industry.
-
Republicans Call on Olympic Committee to Bar Transgender Women From Women’s Sports
More than two dozen G.O.P. members of the House and Senate called on the International Olympic Committee to align its eligibility rules with President Trump’s transgender sports ban.
-
Why Are Cats Such a Medical Black Box?
Many aspects of feline health remain a mystery, even to experts. Our cat-owning reporter learned this the hard way.
-
Trump Vows to Buy a Tesla to Support Musk After Shares Plunge
The president defended Elon Musk, a key donor and adviser, after shares in the electric-car maker hit their lowest point since before Election Day.
-
Japan Fails to Win Tariff Exemptions During Washington Visit
The country’s trade minister stressed its role as a top investor and employer in the United States in a bid to avoid being hit by new levies on metals and cars.
-
Solar Energy, Criticized by Trump, Claims Big U.S. Gain in 2024
The added capacity for the year was the most from any single source in more than two decades.
-
Musk’s Team Must Produce Documents to Comply With Open Records Laws, Judge Says
A federal judge in Washington ordered Elon Musk’s team and the Office of Management and Budget to begin releasing internal documents “as soon as practicable.”
-
The U.S. Is Trying to Deport Mahmoud Khalil, a Legal Resident. Here’s What to Know.
Mr. Khalil, who helped lead protests at Columbia University against high civilian casualties in Gaza, was arrested by immigration officers and sent to a detention center in Louisiana.
-
Your Bag’s Hidden Journey From Check-In to Plane
To get to a plane’s cargo hold, the average checked bag flown with Delta Air Lines is guided by nine people and travels on miles of conveyor belts. We spent a day at LaGuardia Airport to get an inside look.
-
Federal Circuit Refuses to Rehear Case Involving Orange Book Listing of Device Patents
Late last year we reported on the United States Court of Appeals for the Federal Circuit decision holding that certain device patents should not have been listed in the FDA’s Orange Book since the claims of the patents in question did not recite the active drug substance….By: Polsinelli
